Thymopoiesis strictly depends on the function of the Foxn1 transcription factor that is expressed in the thymic epithelium. During embryonic development, initial expression of the Foxn1 gene is induced in the pharyngeal endoderm by mesenchyme-derived BMP4 signals. Here, by engineering a time-delayed feedback system of BMP inhibition in mouse embryos, we demonstrate that thymopoiesis irreversibly fails if Foxn1 gene expression does not occur during a defining time span in mid-gestation. We also reveal an epistatic interaction between the extent of BMP signalling and the gene dosage of Foxn1. Our findings illustrate the complexities of the early steps of thymopoiesis and indicate that sporadic forms of thymic hypoplasia in humans may result from the interaction of genes affecting the magnitude of BMP signalling and Foxn1 expression.
. Subsequently, BMP4 signals back to the endodermal compartment to initiate the expression of Foxn1, the gene encoding a key transcriptional regulator required for the differentiation of the future thymic epithelium [2] [3] [4] . The mesenchymal contribution to thymopoiesis is crucial, as demonstrated by the formation of poorly developed thymic lobes after ablation of the neural crest in chicken 7 , dysplasia of the thymus after inhibition of BMP signalling in the pharyngeal arches 8 or in the thymic rudiment 9, 10 , failure of T cell differentiation in cultured fetal thymic lobes after removal of the mesenchyme 11 , and dysplasia of the thymus in the chromosome 22 deletion (also known as DiGeorge) syndrome 12 . Interestingly, however, the requirement for BMP4 signalling from the mesenchyme appears to be only transient, at least in chicken 6 . The same may hold true in mice, since Foxn1 expression is maintained after deletion of Bmp4 in the mesenchymal compartment through the use of a Foxg1:Cre transgene 13 , although this depletion may only be partial. Collectively, these data indicate that after a short inductive period, Foxn1 expression becomes independent of BMP4.
Here, we set out to answer some of the unresolved questions of early thymus development. For instance, it is not known whether the function of Foxn1 itself is required during the sensitive phase of induction, or whether other factor(s) induced by BMP4 signalling are required to establish thymic epithelial fate. Moreover, it is unclear whether the activity of the dysplastic thymus resulting from perturbed BMP4 signalling during embryogenesis recovers during later stages of development, for instance by BMP4 signals arising from tissue adjacent to the thymus. We have addressed these questions by examining the possible presence of epistasis between BMP4 signals ) mice uniformly expresses Foxn1, although the rudiment tends to be smaller [16] [17] [18] [19] [20] than in Foxn1 +/+ siblings (see Fig. 2 ). (f) In E15. 
Results
Specification of thymic epithelial cells by BMP4 signalling. Thymic epithelial cells (TECs) are characterized by the expression of the gene encoding the transcription factor Foxn1. During embryonic development, BMP4 emanating from the mesenchyme of the pharyngeal pouch induces the expression of Foxn1 in the underlying endoderm to establish the future thymic microenvironment 6 (Fig. 1a) . At embryonic day 13.5 of development (E13.5), BMP4 expression is detectable in the epithelial thymic rudiment and its mesenchymal capsule, although the expression levels in individual cells of the epithelium are variable 9 ( Supplementary Fig. 1a) ; by contrast, BMP4 is not expressed in the adjacent anlage of the parathyroid 14 . In the present context, it is important to point out that BMP4 expression is also readily detectable in the non-functional thymic anlage of Foxn1 −/− mice ( Supplementary  Fig. 1b,c) , supporting the notion that BMP4 functions upstream of Foxn1 (Fig. 1a) .
In order to dampen the initial period of BMP4 signalling during early thymus development, we expressed NOGGIN, a known inhibitor of BMP4, in thymic epithelial cells under the control of the Foxn1 promoter (Fig. 1b) . In this situation, initial BMP signalling from the mesenchyme activates not only the endogenous Foxn1 gene, but also the Foxn1:Noggin transgene in the future thymic epithelium (Fig. 1b) . Hence, this creates a time-delayed feedback inhibition of BMP signalling via the production of NOGGIN in epithelial cells. In contrast to the situation in wild-type mice, in which all TECs are Foxn1-positive at this stage of development 4, 15 (Fig. 1c) , the condition of reduced BMP4 signalling has transformed the thymic rudiment into a mosaic comprising Foxn1-positive and Foxn1-negative epithelial cells 9 (Fig. 1d) ; of note, it was previously shown that the Foxn1-negative cells in the cystic rudiment arise as a consequence of the failure to maintain Foxn1 expression 10 . Hence, sufficient levels of BMP4 signalling are required during early development to establish an epithelial domain stably expressing Foxn1. Because the levels of Bmp4 expression appear to vary in different parts of the embryonic thymic anlage, the extent of suppression of BMP4 signalling (resulting from different degrees of competition with the inhibitor) likewise varies; cells with the highest levels of Bmp4 expression in the wild-type embryo 9 exhibit the greatest resistance to the inhibitory effects of NOGGIN. The secreted BMP4 inhibitor NOGGIN does not perturb the function of the parathyroid despite the fact that the parathyroid is -like the thymus -a derivative of the third pharyngeal pouch endoderm and develops in close apposition to the thymic anlage; it is conceivable that in the transgenic situation increased levels of the BMP inhibitor are functionally irrelevant for the specification of the parathyroid (which is revealed by the activity of the Gcm2 transcription factor gene 14 ) , because the epithelium of the parathyroid itself expresses the Noggin gene 14 . Reduced BMP activity in the thymic domain, however, affects the separation of the thymic and parathyroid rudiments; while most Gcm2-expressing cells form a compact organ rudiment, some Gcm2-positive cells can be found in or near the Foxn1-expressing region ( Supplementary Fig. 2a ). However, this extrathymic effect of BMP inhibition is not related to the emergence of Foxn1-deficient epithelium in the transgenic thymic anlage, as the separation of the thymus and parathyroid occurs normally in Foxn1 −/− mice ( Supplementary Fig. 2b,c) , and hence is due to a function genetically upstream of Foxn1. , and accompanied by a mild reduction of thymus size, the extent of which depends on species and strain [16] [17] [18] [19] [20] . Note, however, that this reduction is not caused by the appearance of Foxn1-negative epithelium in Foxn1 heterozygous mice, since the density of Foxn1-expressing TECs in the thymic rudiment is indistinguishable from that of their Foxn1 +/+ counterpart (c.f., Fig. 1c and Fig. 1e ). By contrast, the thymic anlage of heterozygous Foxn1 +/− ; Foxn1:Noggin transgenic mice contains twice as many Foxn1-negative TECs ( Impaired BMP signalling during embryogenesis permanently reduces the number of thymopoietically active epithelial cells. Collectively, the above results indicate that under the condition of limiting BMP4 signalling in Foxn1:Noggin transgenic thymi, fewer TEC progenitors are established in early embryogenesis, a situation quantitatively equivalent to that resulting from sub-total TEC ablation 15 . It was of particular interest, therefore, to examine whether the small numbers of TEC progenitors would be capable of expanding after the BMP-sensitive period of development 6 to eventually restore near-normal numbers of thymopoietically active TECs. the internal carotid artery is indicated with a white asterix in panels (d) and (f), and the thymic anlagen are encircled with dashed red lines. (g) Foxn1 heterozygosity in Foxn1:Noggin transgenics increases the Foxn1-negative fraction of the thymic epithelium from 33.1 ± 3.2% (mean± s.e.m.) to 65.9 ± 2.9% (mean ± s.e.m.); see Supplementary Figs 3 and 4 for original data underlying these summary statistics. Scale bars, 100 μm.
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Foxn1-deficient TECs do not possess thymopoietic activity 4, 15 ; hence, T cell development in Foxn1:Noggin transgenic thymi is supported only by the small number of Foxn1-positive TECs remaining in the rudiment, as revealed by the expression of the early thymocyte marker granzyme A 21 ( Fig. 2a) . Owing to the difficulties encountered in reliably determining the numbers of haematopoietic cells and TECs in the ectopic thymic lobes of Foxn1:Noggin transgenic embryos, we quantified thymopoietic activity in transgenic mice at 4 weeks of age. At this stage, the thymus of Foxn1 +/+ wild-type mice contains approximately 1.2 × 10 8 thymocytes, whereas only approximately 9 × 10 6 thymocytes can be recovered from the thymus of Foxn1 +/+ ;Foxn1:Noggin transgenics (Fig. 2b) ; note that in our previous study 9 , the precise numbers of thymocytes in the ectopic thymi were not recorded. Interestingly, under conditions of Foxn1 heterozygosity, the deleterious effect of the Foxn1:Noggin transgene on thymocyte numbers is more severe; the cellularities of Foxn1 +/− and Foxn1
;Foxn1:Noggin thymi differ by more than 3 orders of magnitude, resulting in less than 10 4 thymocytes per rudiment (Fig. 2b) . Because the numbers of TECs in the thymi of the four genotypes vary only slightly (the differences did not achieve statistical significance; 22 is indicated in red; the difference to the observed values is estimated to be significant at P < 0.01. In (b) to (d), means ± s.e.m for 4-week-old mice. Fig. 2c) , the considerably lower thymopoietic indices (number of thymocytes per TEC) likely reflect the presence of a large proportion of functionally inactive TECs in the Foxn1:Noggin transgenics (Fig. 2d) . Although Foxn1-negative TECs are already apparent during embryonic development ( Fig. 1; Supplementary Figs 3 and 4) , the discrepancies between the thymopoietic capacities of Foxn1-sufficient and Foxn1 heterozygous transgenics is striking. Numerically, whereas one TEC in the wild-type situation supports on average about 1,000 thymocytes, one TEC in Foxn1 +/− ;Foxn1:Noggin thymi supports less than 1 thymocyte. Hence, assuming that the thymopoietic capacities of Foxn1-expressing TECs that remain in the transgenic thymi are similar to those of their non-transgenic counterparts, we estimate that at 4 weeks of age approximately 15% of TECs remain functional (i.e., stably express Foxn1) in the Foxn1 +/+ ;Foxn1:Noggin genotype, whereas in the Foxn1 +/− ;Foxn1:Noggin genotype, the same is true for less than 0.1% of TECs. Nonetheless, despite their reduced numbers, thymocytes execute their normal developmental programme in the transgenic environments ( Supplementary Fig. 5 ).
Epistatic interaction of BMP signalling and Foxn1 copy number. Genetic interaction analysis can be used to infer the mechanism by which two or more perturbations affect a particular phenotype 22 . In genetic interaction analysis, a so-called synthetic interaction is said to occur when a double mutant exhibits a more extreme phenotype than expected from single-mutant phenotypes; in this case, the two genes often function in distinct but compensatory pathways. By contrast, in the case of alleviating or suppressing interactions, the phenotype is less severe than would have been expected from the individual contributions. The latter types of interactions often occur when the gene products function in the same pathway, so that the mutation in one gene masks or suppresses the effects of the mutation in the other. The thymopoietic index of Foxn1 +/− ;Foxn1:Noggin mice is reduced more than 1,000 fold (Fig. 2d) compared to that of wild-type mice; this reduction is much greater than would have been expected from the effects of the combined individual contributions, that is, Foxn1 heterozygosity (no change) and the Foxn1:Noggin transgene (less than 10 fold reduction). Considering the observed synthetic interaction in the context of prevailing theories of genetic interactions 22 , we conclude that BMP signalling and Foxn1 dosage predominantly act in parallel pathways converging on the number of functional TECs.
Loss of lineage identity in thymic epithelial cells. Given the low thymopoietic activity of Foxn1:
Noggin transgenics, we next examined the structure of the microenvironment in the ectopic thymic lobes. In contrast to the clear separation of the cortical and medullary regions of a wild-type thymus, as revealed by immunohistochemistry with antibodies directed against keratin 18 and keratin 5, respectively (Fig. 3a) , the small thymic lobes of Foxn1 +/+ ;Foxn1:Noggin mice exhibited an unusual structure with hypoplastic keratin 5-positive areas (Fig. 3b) . The lower magnification of Foxn1 +/+ ;Foxn1:Noggin thymi shown in Fig. 3c highlights the cystic nature of the structure and an unexpected inversion of epithelial characteristics, with keratin 5-positive epithelia situated at the rim of the thymus instead of being located within the lobe. Using Ly51 and UEA-1 as markers of cTEC-and mTEC-like cells, we noted the presence of an unusual population of Ly51 −/lo /UEA-1 − epithelial cells ( Fig. 3d; Supplementary Fig. 6 ). The aberrant surface phenotype of the thymic epithelium is magnified in Foxn1 +/− ;Foxn1:Noggin mice, in which the thymus consists of a large cyst; keratin 5-positive epithelial cells occupy a basal location and only few, if any, haematopoietic cells are present (Fig. 3e) . The Ly51 −/lo /UEA-1 − cell surface phenotype of transgenic epithelial cells now predominates ( Fig. 3f; Supplementary Fig. 6 ), in line with the associated minimal thymopoietic activity; this is a clearly different situation to that in the Foxn1-deficient epithelium, in which the majority of cells are entirely negative for the Ly51 and UEA-1 markers (Fig. 3g) .
Next, we examined the expression profile of Foxn1-negative cells in the transgenic rudiment by RNA in situ hybridization using additional gene probes. Given the close developmental relationship of the thymic rudiment and the developing parathyroid gland, as well as the expression of Noggin in the parathyroid anlage (presumably to suppress BMP signalling in this region), we initially hypothesized that the emerging Foxn1-negative epithelium in the thymic rudiment might adopt a parathyroid fate. However, this is not the case, since Foxn1-negative cells do not express Gcm2, the defining marker of the parathyroid; instead, Gcm2-positive cells are found closely attached to the thymic rudiment in variable configurations (c.f., Fig. 4a; Supplementary Fig. 2a ). Of note, the thymic rudiment of Foxn1 −/− mice still expresses Foxn1 and Bmp4 (Supplementary Fig. 1 ). By contrast, the Foxn1-negative TECs, which emerge as a result of impaired BMP signalling, express neither (Fig. 4b) , indicating that the canonical expression characteristics of typical thymic epithelia are lost. We observed that the Foxn1-negative cells express Wnt4 and Wnt10a genes (Fig. 4c) ; these genes are typically expressed in mesenchymal cells of the pharyngeal region, but also in the thymic epithelium 23 , albeit independently of Foxn1 activity (data not shown).
Discussion
This paper addresses a potential mechanism by which reduced BMP signalling and Foxn1 heterozygosity interact to impact the number of functional TECs. We demonstrate that impaired BMP signalling results in the loss of Foxn1 expression in pharyngeal epithelia, and thereby decreases the number of functional TECs in the thymic rudiment. Remarkably, concomitant reduction of Foxn1 levels drastically aggravates this phenotype.
Transient requirement for BMP signals in early stages of thymopoiesis. Mesenchymal BMP signals initiate expression of both Foxn1 and Bmp4
6 in endodermal cells; moreover, it is likely that activation of Bmp4 expression in the epithelium initiates an autoregulatory positive feedback loop 24 that maintains Bmp4 and Foxn1 expression in the future thymic epithelium. Since the presumptive promoter regions of Foxn1 do not contain canonical Smad binding sites (data not shown), it appears unlikely that BMP signalling acts directly on Foxn1 expression. Rather, BMP signalling might in parallel induce the establishment of a genetic network in thymic epithelial cells to maintain expression of the Foxn1 transcription factor. If, however, BMP signalling is extinguished early in the development of the thymic rudiment via the action of BMP inhibitors (in the present case NOGGIN), the expression of both Foxn1 and Bmp4 genes in the epithelium rapidly ceases. As a result, a substantial fraction of epithelial cells in the thymus exist in a non-functional, Foxn1-negative state. Importantly, after the BMP-sensitive phase of thymopoiesis, NOGGIN emanating from the residual Foxn1-expressing TECs appears to be functionally inert; this suggests that the genetic network maintaining Foxn1 expression in TECs has by then become independent of BMP signals. This model explains previous findings that BMP signals are required for only a short period during the early phases of thymopoiesis 6 . We also demonstrate that in Foxn1:Noggin transgenic mice, the phenotype of epithelia after a somatically acquired state of Foxn1-deficiency is different from that of heritable Foxn1-deficiency, as indicated by discordant gene expression patterns. More specifically, genetically Foxn1-deficient TECs remain in a latent state for extended periods of time and can become functional stromal cells upon supply of a wild-type Foxn1 gene 25 . By contrast, Foxn1-deficiency as a result of insufficient BMP signalling during the early phases of TEC development likely establishes an alternative epithelial fate unrelated to canonical thymic stroma.
Our transgenic system was designed to exhibit self-inactivating properties, in order to test whether the BMP-mediated thymic epithelial differentiation process is sensitive to developmental timing. This proved to be the case, since Foxn1 expression cannot be re-established even after the removal of the BMP blockade. It appears therefore that sufficient BMP signals are available to the thymic rudiment only during a certain developmental window, possibly associated with a particular microenvironment. We note that normal mouse development entails drastic remodelling of spatial tissue relationships (migration of thymus to the mediastinum), which breaks down in the transgenic situation, as evidenced by the failure of the separation of parathyroid and thymic rudiments. These morphogenetic changes during development may provide an explanation for the time-sensitivity of TEC formation. This conclusion is supported by our previous observation that cervical thymi 26 develop at a later stage than the thoracic thymus 15 , possibly owing to a different signalling environment in the neck.
Foxn1 gene copy number influences the fitness of TECs. Using tetraparental chimaeras, it was previously shown that the niche maintaining thymic epithelial progenitors is of finite size; Foxn1-deficient thymic epithelial cells appear to be situated in the relatively quiescent progenitor niche of the thymus, thus permanently reducing the supply of thymopoietically competent TECs arising from neighbouring Foxn1 +/+ progenitors 27 . Our results are compatible with this notion, since the functional TEC compartment in Foxn1 minority under conditions of Foxn1 heterozygosity, when compared to the embryonic situation with a relatively large contribution of Foxn1-expressing cells. The ensuing cystic transformation of the postnatal transgenic thymus represents a considerable challenge for future studies addressing the spatial distribution of the remaining thymopoietically active TECs and associated developing thymocytes.
Given the qualitative changes observed for the epithelial compartment in the thymus of Foxn1:Noggin transgenic mice, we believe that these results cannot provide an explanation for the phenomenon of reduced output of thymocytes under conditions of Foxn1 heterozygosity [16] [17] [18] [19] [20] . Indeed, the observation that the thymopoietic index of Foxn1 +/− thymi is indistinguishable from that of Foxn1 +/+ thymi supports the conclusion that Foxn1 haploinsufficiency is caused by quantitative, but not qualitative, changes in the TEC compartment. How Foxn1 heterozygosity affects proliferative capacity in the TEC compartment is currently unknown, but may be related to diminished responses to proliferative signals, such as those mediated by the Fgfr2IIIb receptor expressed on thymic epithelial cells 28 .
Epistatic control of thymopoiesis. The synthetic genetic interaction observed here between the magnitude of BMP signalling and Foxn1 gene dosage has important implications. Gene dosage of BMP4 is known to affect developmental traits 29 , and the genetic background affects the degree of ectodermal pathology associated with Foxn1 heterozygosity in humans 30 ; it is therefore conceivable that even subtle changes in BMP signalling and Foxn1 expression levels could lead to unexpectedly severe effects with respect to thymopoietic activity. However, it is likely that factors other than BMP signalling and Foxn1 dosage also impact on the formation of the initial TEC progenitor pool, giving rise to complex genetic interactions with unexpected outcomes; such phenomena may underlie sporadic thymic dysplasia in human patients, for instance those with Nezelof syndrome 31 . As a further illustration of this possibility, a recent study in mice has identified a quantitative trait locus on chromosome 3 near marker D3Mit127 (situated at 143 Mb) affecting the number of thymocytes and interacting with a locus on the X chromosome 32 ; interestingly, the gene for BMPR1B, an essential component of the BMP receptor, is located on chromosome 3 (at 141 Mb) within the critical interval, raising the possibility that differences in the strength of BMP signalling (in this case influenced by an unknown gene on chromosome X) underlie this phenotypic variation.
Methods
Mice. The Foxn1:Noggin transgenic mice were described earlier 9 , as were Foxn1 knock-out mice 4 . Mice were kept in the animal facility of the Max Planck Institute of Immunobiology and Epigenetics under specific pathogen-free conditions. All animal experiments were performed in accordance with the relevant guidelines and regulations, approved by the review committee of the Max Planck Institute of Immunobiology and Epigenetics and the Regierungspräsidium Freiburg, Germany (licence AZ 35-9185.81/G-12/85).
Histology. Embryos for haematoxylin and eosin staining and RNA in situ hybridisation were fixed in 4% PFA and subsequently embedded in paraffin using standard techniques.
RNA in situ hybridization. RNA in situ hybridisation (ISH) on paraffin sections was performed using DIG-labelled probes as described 33 . Sequences for the various probes used are as follows: Foxn1, nucleotides 2181-3584 in Genbank Accession number XM_006532266.3; Gcm2, nucleotides 615-1540 in Genbank Accession number NM_008104.2; GzmA, nucleotides 211-1019 in Genbank Accession number M13226.1; Bmp4, nucleotides 834-1337 in Genbank Accession number NM_001316360.1; Wnt4, nucleotides 340-1094 in Genbank Accession number NM_009523.2; Wnt10a, nucleotides 153-1407 in Genbank Accession number NM_009518.2.
Image analysis. Images were acquired on a Zeiss Axioplan 2 microscope equipped with an AxioCam MRc 5 camera. Foxn1-positive and Foxn1-negative areas in the embryonic thymus were determined after RNA in situ hybridization.
Immunofluorescence. Sections from paraformaldehyde (PFA)-fixed, paraffin-embedded tissue were de-paraffinised in xylene, re-hydrated, and then subjected to antigen retrieval with Tris-EDTA buffer (10 mM Tris, 1 mM EDTA, 0.05% Tween 20, pH 9.0) in a steamer for 17 minutes. Sections were subsequently washed in PBS-Tween 20 (0.05%) and permeabilised with 1% TritonX-100. Antibody staining was performed at room temperature in staining buffer (PBS supplemented with 4% serum and 0.05% BSA). Sections were stained for 1 hour with primary antibodies (see Supplementary Table 1) , and then for 30 minutes with secondary antibodies and streptavidin. Sections were washed with PBS-Tween 20 (0.5%) between incubations. After staining, sections were mounted in Fluoromount G and images were acquired on a Zeiss Imager Z1 with ApoTome attachment using an Axiocam MRm camera.
Flow cytometry. To generate single cell suspensions for TEC staining, thymi were finely minced with scissors, and then digested with a cocktail of collagenase type 4 (200 µg/mL), neutral protease (200 µg/mL) and DNaseI (500 ng/mL) in RPMI 1640 + 2% FCS for up to 90 minutes at 37 °C with agitation. Following digestion, EDTA was added to a final concentration of 2 mM to disaggregate any remaining cell clumps; this procedure consistently resulted in a single-cell suspension of thymocytes and stromal cells. Cells were then washed with RPMI 1640 + 2% FCS, and then re-suspended in PBS/BSA for staining. Thymocyte suspensions for CD4/CD8 staining were generated by gently pressing thymic lobes through 40 µm sieves. Cell surface staining (see Supplementary  Table 1 for antibodies) was performed at 4 °C in PBS supplemented with 0.5% BSA and 0.02% NaN 3 . Thymic epithelial cells have the surface phenotype CD45 − /EpCAM + ; thymocytes are CD45 + /EpCAM − .
